Table 4.
RA |
OA |
Other |
||||
---|---|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
Overall | 1.25 (1.11–1.41) | <.01 | 1.32 (1.16–1.5) | <.01 | 1.09 (0.99–1.21) | .07 |
Gender | ||||||
Men | 1.07 (0.88–1.31) | .48 | 1.25 (1.02–1.52) | .03 | 1.16 (0.99–1.36) | .06 |
Women | 1.39 (1.19–1.62) | <.01 | 1.37 (1.16–1.62) | <.01 | 1.06 (0.93–1.2) | .41 |
Age | ||||||
20–39 y | 1.63 (1.13–2.36) | <.01 | 1.72 (1.26–2.35) | <.01 | 1.37 (1.07–1.76) | .01 |
40–59 y | 1.16 (0.96–1.39) | .12 | 1.56 (1.3–1.87) | <.01 | 1.24 (1.05–1.46) | .01 |
≥ 60 y | 1.32 (1.13–1.54) | <.01 | 1.08 (0.92–1.26) | .37 | 0.9 (0.78–1.04) | .15 |
RA: rheumatoid arthritis; OA: osteoarthritis.
All data were adjusted for gender (except gender-specific estimates), age (except age-specific estimates), race, health insurance coverage, education level, employment status and poverty to income ratio, physical activity, excess sodium intake, ever cigarette smoking, obesity and diabetes.